Relation of Baseline High-Sensitivity C-Reactive Protein Level to Cardiovascular Outcomes With Rosuvastatin in the Justification for Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)
Paul M. Ridker(Brigham and Women's Hospital), Jean MacFadyen, Peter Libby(Harvard University), Robert J. Glynn
Cited by 155Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis